Shaoshui Chen

1.1k total citations
16 papers, 327 citations indexed

About

Shaoshui Chen is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shaoshui Chen has authored 16 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shaoshui Chen's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (3 papers). Shaoshui Chen is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Cancer-related molecular mechanisms research (3 papers). Shaoshui Chen collaborates with scholars based in China and France. Shaoshui Chen's co-authors include Jingmin Li, Dong Wang, Xianyong Bai, Fangfang Yang, Feng Wang, Changmin Liu, Baosheng Li, Chuanxin Wang, Shengnan Hao and Zhonghua Zhao and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Pharmacology and BioMed Research International.

In The Last Decade

Shaoshui Chen

16 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoshui Chen China 9 169 109 97 70 39 16 327
Libo Si China 14 296 1.8× 128 1.2× 76 0.8× 60 0.9× 26 0.7× 29 406
Lokman Varışlı Türkiye 11 261 1.5× 100 0.9× 94 1.0× 88 1.3× 29 0.7× 28 410
Yolla Haibe Lebanon 8 196 1.2× 106 1.0× 155 1.6× 51 0.7× 49 1.3× 15 404
Shuye Lin China 11 162 1.0× 71 0.7× 51 0.5× 46 0.7× 47 1.2× 18 270
Yunhong Zhan China 10 280 1.7× 153 1.4× 130 1.3× 152 2.2× 47 1.2× 14 450
Yoshihiro Tanimori Japan 9 184 1.1× 136 1.2× 135 1.4× 33 0.5× 35 0.9× 9 379
Feng-Mei Zhou China 10 127 0.8× 82 0.8× 53 0.5× 60 0.9× 26 0.7× 25 286
Vignesh Ramesh India 9 230 1.4× 142 1.3× 113 1.2× 73 1.0× 28 0.7× 18 400

Countries citing papers authored by Shaoshui Chen

Since Specialization
Citations

This map shows the geographic impact of Shaoshui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoshui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoshui Chen more than expected).

Fields of papers citing papers by Shaoshui Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoshui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoshui Chen. The network helps show where Shaoshui Chen may publish in the future.

Co-authorship network of co-authors of Shaoshui Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoshui Chen. A scholar is included among the top collaborators of Shaoshui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoshui Chen. Shaoshui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lü, Shun, Jianhua Chen, Gongyan Chen, et al.. (2022). Aumolertinib activity in patients with CNS metastases and EGFR-mutated NSCLC treated in the randomized double-blind phase III trial (AENEAS).. Journal of Clinical Oncology. 40(16_suppl). 9096–9096. 8 indexed citations
2.
3.
Zheng, Jing, et al.. (2021). Mitigation of acute radiation-induced brain injury in a mouse model using anlotinib. Annals of Palliative Medicine. 10(1). 312–322. 8 indexed citations
4.
Liu, Changmin, Roger Sun, Jing Wang, et al.. (2020). Combination of DCE‐MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma. BioMed Research International. 2020(1). 2576563–2576563. 7 indexed citations
5.
Wan, Jin-Liang, Zhen‐Bo Wang, Lei Li, et al.. (2020). miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer. Technology in Cancer Research & Treatment. 19. 1079191075–1079191075. 4 indexed citations
6.
Han, Xia, et al.. (2019). Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer. Cancer Biomarkers. 25(4). 325–332. 13 indexed citations
7.
Chen, Shaoshui, et al.. (2019). Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells.. PubMed. 23(3). 814–819. 7 indexed citations
8.
Wang, Zhen‐Bo, et al.. (2018). Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer. Oncology Reports. 40(5). 2778–2787. 6 indexed citations
9.
Zhang, Jing, Ling Zhou, Qing Yuan, et al.. (2017). Knockdown of c-Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation. Oncology Reports. 38(4). 2471–2479. 22 indexed citations
10.
Zhao, Zhonghua, Xi Chen, Shengnan Hao, et al.. (2016). Increased interleukin-35 expression in tumor-infiltrating lymphocytes correlates with poor prognosis in patients with breast cancer. Cytokine. 89. 76–81. 34 indexed citations
11.
Yang, Fangfang, et al.. (2015). Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. European Journal of Pharmacology. 754. 105–114. 85 indexed citations
12.
Wang, Zhen‐Bo, Xiaole Wang, Yufeng Cheng, et al.. (2015). Radiation dose is associated with prognosis of small cell lung cancer with superior vena cava syndrome.. PubMed. 8(3). 4263–8. 6 indexed citations
13.
Wang, Feng, et al.. (2014). MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Diagnostic Pathology. 9(1). 143–143. 67 indexed citations
14.
Wang, Feng, et al.. (2014). Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer. Cell Biochemistry and Biophysics. 71(2). 1261–1265. 19 indexed citations
15.
Liu, Jianwei, et al.. (2014). OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC. International Journal of Genomics. 2014. 1–6. 12 indexed citations
16.
Chen, Shaoshui, Xiaochun Yang, Feng Chi, et al.. (2013). A Phase II Study of Preoperative Chemotherapy With Modified FOLFOX6 Followed by Surgery and Postoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(7). 327–332. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Libo Si Breakdown of academic impact, for papers by Lokman Varışlı Breakdown of academic impact, for papers by Yolla Haibe Breakdown of academic impact, for papers by Shuye Lin Breakdown of academic impact, for papers by Yunhong Zhan Breakdown of academic impact, for papers by Yoshihiro Tanimori Breakdown of academic impact, for papers by Feng-Mei Zhou Breakdown of academic impact, for papers by Vignesh Ramesh
Rankless by CCL
2026